C

Concertai

www.concertai.com link_icon

ConcertAI Company Market Research Report



Company Overview


  • Name: ConcertAI

  • Mission: To accelerate high confidence and actionable insights and outcomes for patients through multi-modal data, AI technologies, and scientific expertise in collaboration with leading biomedical innovators, health care providers, and medical societies.

  • Founded: No information is available.

  • Founders: No information is available.

  • Key People:

  • Jeff Elton, PhD, CEO

  • Headquarters: Cambridge, MA

  • Number of Employees: No information is available.

  • Revenue: No information is available.

  • Known For: Leader in Generative AI technology and Real-World Evidence (RWE) solutions for life sciences and healthcare.


Products


Real-World Data Products


  • Description: Provides comprehensive real-world data for research needs.

  • Key Features:

  • On-demand access to structured fields such as labs, visits, observations, procedures, medications, and diagnoses.

  • Enriched data for disease progression, adverse events, and specialty pharmacy & hub.


Digital Trial Solution (DTS)


  • Description: Enhances the clinical trial process through digital solutions.

  • Key Features:

  • Optimization of study design and trial planning.

  • Longitudinal data integration.


Clinical Trial Optimization (CTO)


  • Description: Enhances efficiency and effectiveness of clinical trials.

  • Key Features:

  • Advanced data analytics.

  • AI and model-based insights for trial planning.


TeraRecon


  • Description: Advanced visualization tools for medical imaging.

  • Key Features:

  • Cutting-edge visualization tools.

  • AI-driven diagnostics.


Eureka Clinical AI


  • Description: AI-powered clinical analytics platform.

  • Key Features:

  • Advanced analytics for clinical trials.

  • Enhanced data integration.


CancerLinQ


  • Description: Data-driven platform focused on oncology.

  • Key Features:

  • Real-world data aggregation.

  • Advanced analytics for cancer research.


Commercial Solutions


  • Description: Supports better patient outcomes through technology.

  • Key Features:

  • Actionable patient insights.

  • Optimized prescription efficiency.


Patient Engagement Platform


  • Description: Platform designed to enhance patient adherence and engagement.

  • Key Features:

  • Tools to increase patient adherence.

  • Enhanced patient communication solutions.


Recent Developments


Collaborative Agreements and Partnerships


  • ConcertAI & NeoGenomics: Collaboration to advance population-scale, definitive hematological research & generative AI solutions.

  • ConcertAI & Caris Life Sciences: Expansion of partnership to accelerate oncology pipeline and clinical trials.

  • ConcertAI & PathAI: Partnership to create first-in-class histopathology and curated clinical RWD product.

  • ConcertAI & AbbVie: Strategic agreement to accelerate oncology pipeline and clinical trials.

  • ConcertAI & Janssen Pharmaceuticals: Expanded partnership for advancing oncology research.

  • ConcertAI & Bristol Myers Squibb: Advancement of novel oncology accelerated digital clinical trial solution.


FDA Collaboration


  • Objective: To advance use of Real-World Evidence (RWE).


Technology and Innovation


  • NVIDIA Collaboration: Advancement of translational and clinical development solutions.

  • Integration of TeraRecon: Enhanced visualization and diagnostics for medical imaging.


Financial Milestones


  • Series C Funding: Raised $150 million from Sith Street at $1.9 billion valuation.


Certifications and Accolades


  • Great Place to Work Certification: Awarded 2022-23 certification recognizing excellent workplace culture.


Events


  • ASH Annual Meeting & Exposition 2024: Discussing advanced analytics and AI insights in hematology.

  • ISPE Annual Meeting 2024: Focus on breakthroughs in pharmacoepidemiology through AI.

  • ASCO Quality Care Symposium 2024: Showcasing impact on patient care in oncology.

  • ESMO Congress 2024: Transforming oncology through AI and data analytics.

  • BioTechX Europe 2024: Innovations in precision medicine and cancer therapies.

  • AACI/CCAF Annual Meeting 2024: Enhancing treatment advances and clinical discoveries in cancer centers.

  • hlth. 2024: Pinnacle of innovation in healthcare through advanced AI technologies.

  • RSNA 2024: Innovations in medical imaging and diagnostics.


Conclusion


ConcertAI demonstrates continual advancements through strategic partnerships, cutting-edge technology integrations, and landmark financial achievements, solidifying its position as a leading entity in AI-driven healthcare solutions. The company’s extensive range of products and collaborative approaches indicates a robust stance towards transformative cancer and healthcare solutions.